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During each heartbeat, intercellular electrical
coupling via connexin43 (Cx43) gap junctions en-
ables synchronous cardiac contraction. In failing
hearts, impaired Cx43 trafficking reduces gap junc-
tion coupling, resulting in arrhythmias. Here we
report that internal translation within Cx43 (GJA1)
mRNA occurs, resulting in truncated isoforms that
autoregulate Cx43 trafficking. We find that at least
four truncated Cx43 isoforms occur in the human
heart, with a 20 kDa isoform predominating. In-frame
AUG codons within GJA1 mRNA are the translation
initiation sites and their ablation arrests trafficking
of full-length Cx43. The 20 kDa isoform is sufficient
to rescue this trafficking defect in trans, suggesting
it as a trafficking chaperone for Cx43. Limiting cap-
dependent translation through inhibition of mTOR
enhances truncated isoform expression, increasing
Cx43 gap junction size. The results suggest that
internal translation is a mechanism of membrane
protein autoregulation and a potent target for thera-
pies aimed at restoring normal electrical coupling in
diseased hearts.
INTRODUCTION
Gap junctions, which are comprised of connexin proteins, pro-
vide the intercellular coupling that is necessary for rapid action
potential propagation through the myocardium, triggering syn-
chronized heart contraction (Rohr, 2004; Shaw and Rudy,
1997). Connexin43 (Cx43) is the most commonly expressed of
the 21 human connexins, occurs in all organ systems, and is
particularly enriched in ventricular cardiomyocytes (Beyer
et al., 1987). Six Cx43 molecules oligomerize to form transmem-
brane channels, termed connexons, that couple with apposing
connexons on neighboring cells and coalesce into dense gap
junction plaques (Unwin and Zampighi, 1980). Given the broad
expression pattern of Cx43, it is unsurprising that alterations in
Cx43 gap junction coupling are associated with diverse pathol-
ogies, including heart disease (Akar et al., 2007; BeardsleeCeet al., 2000; Luke and Saffitz, 1991; Smith et al., 1991), connec-
tive tissue disease (Paznekas et al., 2003), and cancer (Solan
et al., 2012). In fact, altered Cx43 trafficking contributes to the
arrhythmias of sudden cardiac death (Kalcheva et al., 2007; Pe-
ters et al., 1997; Remo et al., 2011; Shaw and Rudy, 1997; Smyth
et al., 2010).
Gap junction turnover and the Cx43 half-life occur within
several hours (Beardslee et al., 1998; Jordan et al., 1999; Shaw
et al., 2007). Regulation of Cx43 trafficking is therefore a critical
and continuous cellular need. Ion channel function and traf-
ficking are usually regulated by related auxiliary protein subunits
(Smyth and Shaw, 2010). To date, no such auxiliary molecules
that are specific to connexins have been identified, and the
mechanisms that regulate anterograde transport of Cx43 from
the cell interior to the surface remain under investigation (Shaw
et al., 2007; Smyth et al., 2010).
Human Cx43 is encoded by the GJA1 gene, which comprises
two exons, and the entire coding sequence of the Cx43 protein
resides within the second exon (Fishman et al., 1991). Only the
50 UTR of GJA1mRNA has been reported to undergo alternative
splicing events (Pfeifer et al., 2004). Recent data indicate that
eukaryotic internal ribosome entry sites (IRES) exist as a form
of translational regulation, and cap-independent translation
events are now accepted as a powerful, but previously underap-
preciated, mechanism of posttranscriptional protein regulation
(Candeias et al., 2006; Ingolia et al., 2011). Interestingly, an
IRES element has been found within the 50 UTR of GJA1
mRNA (Schiavi et al., 1999), but not within the coding sequence.
We are not aware of internal translation sites being identified for
Cx43 or any mammalian membrane channel.
We previously found that altered Cx43 intracellular trafficking
contributes to losses in cell-cell coupling in diseased hearts
(Smyth et al., 2010, 2012). In this study, we present the finding
that Cx43 trafficking is genetically autoregulated by chaperone
proteins generated through internal translation events within
the coding sequence of Cx43 (GJA1) mRNA. In human heart
and cell lines, several truncated isoforms of Cx43 that en-
compass the C terminus of Cx43 are detectable. Mutagenesis
experiments reveal that these isoforms originate from internal
translation initiation events, and that loss of their expression ar-
rests full-length Cx43 trafficking. We also find that translation of
these isoforms is regulated by the phosphatidylinositol 3-kinase
(PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway,ll Reports 5, 611–618, November 14, 2013 ª2013 The Authors 611
Figure 1. Multiple C-Terminal Isoforms of Cx43 Occur in Human Heart
(A) Western blot of nonfailing human left ventricle with monoclonal antibody against the Cx43 C terminus. Intensity profiles of five separate hearts were averaged
and plotted in the graph, with peaks corresponding tomajor immunodetectable bands (arrows). Schematic: predictedmethionine-initiated polypeptides and their
molecular weights.
(B) Western blot of HaCaT cells transfected with cDNA encoding EGFP or Cx43.
(C) Cx43 N- and C-terminal HA-tagged fusion proteins expressed in 293T cells. Western blot probed with monoclonal HA antibody.
See also Figures S1 and S2.which promotes cap-dependent translation. Inhibition of mTOR
kinase activity increases the Cx43 gap junction plaque size at
cardiomyocyte cell-cell borders. Taken together, these findings
introduce a paradigm of membrane protein autoregulation
through internal translation and reveal a role for cap-indepen-
dent translation in maintaining electrical coupling in the heart.
RESULTS AND DISCUSSION
We explored expression of Cx43 in the left ventricle of nondi-
seased human hearts. Western blot using a Cx43 C-terminus-
directed antibody reveals multiple distinct bands (Figure 1A).
The dominant band between 40 and 45 kDa is typically reported
for the 43 kDa protein and has been separated into phosphospe-
cific isoforms (Solan and Lampe, 2007). A second dominant
band, which we term GJA1-20k, occurs at 18–20 kDa and has
occasionally been observed in cell lines (Joshi-Mukherjee
et al., 2007). There are as many as five other distinct, but previ-
ously unreported, immunoreactive bands detectable below the
predicted 43 kDa full-length Cx43 protein (we use the term
GJA1-43k) protein (Figure 1A, gray arrows). We then investi-612 Cell Reports 5, 611–618, November 14, 2013 ª2013 The Authorsgated, in different human cell lines, whether the Cx43 isoforms
were also present (Figure S1A). Just as in the human hearts,
the 43 kDa and 20 kDa bands typically predominate and three
middle forms are detectable, with variation between each cell
line. Of note, we find that the dominant GJA1-20k isoform
migrates between 18 and 25 kDa and can occur as a doublet.
We attribute this to altered phosphorylation status of the Cx43
C-terminal region (Solan and Lampe, 2007).
Several mammalian genes have recently been identified to
contain internal translation initiation start sites that permit cap-
independent translation within their coding regions (Ingolia
et al., 2011), and in zebrafish, Cx55.5 can generate distinct
protein isoforms (Ul-Hussain et al., 2008a, 2008b). We hypothe-
sized that human GJA1 mRNA occurs as a polycistronic
molecule and that different isoforms of Cx43 protein arise from
internal translation events. Seven AUG (methionine) codons exist
in frame within the coding sequence of Cx43. When we tested
whether each methionine could be a separate start codon,
in silico analysis of the GJA1 coding mRNA revealed a striking
correlation between the predicted protein size and that of five
anti-Cx43 bands identified (Figure 1A, schematic).
Transfection of cDNA containing the Cx43 coding sequence
under transcriptional regulation of a cytomegalovirus (CMV)
promoter is sufficient to increase expression of four smaller
isoforms in addition to full-length GJA1-43k (Figure 1B). If the
multiple isoforms arise from cleavage of the full-length protein,
one would expect both C-terminal and N-terminal fragments to
exist. However, recognition of truncated isoforms requires anti-
body against the C terminus, and not the N terminus, of Cx43
(Figure S1B, left panel, red arrow), indicating that the N terminus
of Cx43 is contained only in the full-length protein, GJA1-43k
(Figure S1B, right panel). To confirm C terminus specificity, we
generated N- and C-termini Cx43 fusion proteins with the hem-
agglutinin (HA) epitope tag. Only the C-terminally fused Cx43-
HA construct generated detectable smaller HA-tagged isoforms
dominated by the 20 kDa band as seen in human heart, in addi-
tion to full-length GJA1-43k-HA (Figure 1C, arrow). We then
introduced previously described point mutations (R202E and
F199L) that retard trafficking of full-length Cx43 (Olbina and
Eckhart, 2003). Both mutations resulted in loss of gap junction
plaque formation and redistribution of Cx43 to the cytoplasm
(Figure S2A, arrows), yet the presence of truncated isoforms
was not affected by the deficit in cytoplasmic trafficking (Fig-
ure S2B, arrows) suggesting their origin occurs prior to process-
ing later in the vesicular transport pathway.
To confirm that all Cx43 isoforms detected in Figure 1 arise
from the same mRNA molecule, we introduced three distinct
siRNA duplexes into 293T cells. All three duplexes targeted re-
gions of the mRNA sequence more 50 proximal than GJA1-20k,
yet all three were capable of ablating expression of the smaller
isoforms (Figure 2A). We then transfected in vitro transcribed
GJA1 mRNA that is resistant to siRNA (duplex ii in Figure 2A)
into 293T cells following knockdown of endogenous Cx43.
Consistent with the possibility of internal translation initiation
sites, the exogenously generated GJA1 mRNA was sufficient
to encode the major full-length (43 kDa) and smaller (20 kDa)
forms of Cx43 (Figure 2B). If the smaller Cx43 isoforms arise
from internal translation initiation, then the initial start codon
(M1) of the GJA1 gene should not be necessary for their expres-
sion. Indeed, ablation of the GJA1 start codon prevents expres-
sion of the full-length protein, but enhances expression of
smaller isoforms (Figure 2C). The in silico studies shown in Fig-
ure 1A predict that in-frame internal AUG codons of GJA1 can
be initiation sites for the truncated isoforms. We sequentially
mutated each internal methionine codon (AUG) to aspartate
(GAC). Each mutation resulted in loss of the corresponding
predicted Cx43 isoform (Figure 2D, arrows). These data were
confirmed by fusion of an HA epitope tag to the C terminus of
Cx43, where substitution of all six internal methionines with the
more innocuous mutation to leucine (Cx43-ML-HA) also ablated
expression of the smaller isoforms (Figure S2C).
Internal translation within the coding sequence ofGJA1mRNA
may arise from ribosomes that have read through previous start
sites, or by internal ribosomal entry and initiation within the
coding sequence proper. We introduced a potent triple-stop
(TAGTAATGA) signal by mutation at codons 177, 178, and 179
in the Cx43-HA construct (Cx43-180STOP-HA). These codons
occur proximal to M213, so if GJA1-20k (HA tagged) is a result
of ribosomal read-through, its expression should be preventedCeby the early stop codons. As expected, an 18 kDa N-terminal
Cx43 fragment corresponding to residues 1–176 was detectable
in cells transfected with the Cx43-180STOP-HA construct, and
full-length GJA1-43k-HA protein was absent (Figure 2E, red
bands). However, when we probed for HA, we found that the
177,178,179 stop codons failed to inhibit expression of GJA1-
20k (Figure 2E, green bands). These data strongly support
ribosomal entry and initiation of translation, as opposed to
read-through or cleavage, as the mechanism of GJA1mRNA in-
ternal translation.
Cx43 is a molecule with rapid turnover but no known regulato-
ry subunits. We explored the relationship between internally
translated Cx43 isoforms and full-length GJA1-43k trafficking.
Immunofluorescence of 293T cells transfected with wild-type
Cx43 reveals gap junction plaques at cell-cell borders in
78.7% of transfected cell pairs (Figure 3A). Introduction of
sequential additive methionine-to-leucine mutations of their cor-
responding internal start codons (M100L, M125L, M147L, and
M213L) reveals that the loss of all four internal start codons
severely compromises GJA1-43k trafficking. The Cx43M4L
construct encodes a GJA1-43k protein with all four methio-
nine-to-leucinemutations and is largely restricted to cytoplasmic
reticular structures consistent with the endoplasmic reticulum
(ER), with only 12% of cell pairs displaying gap junction plaque
formation (Figures 3A and S3A). Given that GJA1-20k arises
from M213 in the GJA1 coding sequence and is the most
robustly expressed truncated Cx43 isoform, we explored
whether it was sufficient to rescue transport of GJA1-43kM4L.
Indeed, when it is coexpressed with GJA1-20k-V5 (red), trans-
port of full-length GJA1-43kM4L (green) to gap junctions at the
cell surface is rescued, whereas GJA1-20k-V5 remains cyto-
plasmic (Figures 3C and 3D). These data indicate that perturbed
trafficking of GJA1-43kM4L is not a result of mutation of internal
methionines to leucines at the protein level, but rather is due to
loss of the coexpressed truncated isoform(s).
High-resolution immunofluorescence imaging of GJA1-20k-
V5 reveals that this isoform is localized primarily to cytoplasmic
reticular structures (Figure 3C). This compartment was
confirmed as ER/Golgi by immunofluorescence colocalization
studies (Figures S3B and S3C), suggesting a role for GJA1-20k
early in the Cx43 vesicular transport pathway. Indeed, coimmu-
noprecipitation experiments reveal that full-length GJA1-43k
complexes with GJA1-20k, and enrichment of GJA1-43k in the
ER using Brefeldin A increases this interaction (Figure S3E). To
further visualize this interaction and rule out any possible artifact
of immunostaining, we cotransfected 293T cells with constructs
encoding GJA1-20k-mCherry and GJA1-43kML-enhanced GFP
(GJA1-43kML-EGFP). Data comparable to those shown in Fig-
ure 3C were obtained, indicating that GJA1-20k colocalizes
with GJA1-43kML-EGFP in the perinuclear Golgi compartment,
but is not incorporated into gap junction plaques at the cell
surface with the full-length GJA1-43ML-EGFP protein (Figure S4,
arrows). GJA1-20k may therefore act as a chaperone auxiliary
protein, regulating trafficking of de novo GJA1-43k molecules
through the ER/Golgi.
Given the variable expression of truncated Cx43 isoforms in
human cell lines (Figure S1A), we wondered whether their
expression is regulated by signaling pathways associated withll Reports 5, 611–618, November 14, 2013 ª2013 The Authors 613
Figure 2. Truncated Cx43 Isoforms Arise from Internal Translation Initiation Events
(A) Western blot of endogenous Cx43 knockdown in 293T cells using three distinct siRNA duplexes. The schematic illustrates the location of each siRNA targeting
sequence within GJA1 mRNA.
(B) Cx43 western blot of siRNA-resistant in vitro transcribed mRNA transfection of 293T cells with endogenous Cx43 knockdown.
(C) Cx43 western blot following siRNA-resistant Cx43 cDNA transfection with knockdown of endogenous Cx43 in 293T cells. Cx43D-Start contains the AUG-to-
AUA point mutation to ablate the initial M1 start codon.
(D) Cx43 western blot of transfected Cx43 cDNA containing sequential AUG-to-GACmutations for internal methioninesM100, M125, M147, andM213 in addition
to M1. Bands corresponding to internal translation products are highlighted by red arrows.
(E) Multiplex western blot of 293T cells transfectedwith siRNA-resistant wild-type Cx43-HA (left lane) or Cx43-180STOP-HA (right lane), which contains a triplet of
stop codons at codons 177, 178, and 179 (schematic). Blot probed for HA (green) and Cx43 N terminus (red).
See also Figure S2.
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Figure 3. Truncated Cx43 Isoforms Are
Necessary for Trafficking of Full-Length
Cx43 to Gap Junction Plaques
(A) Fixed-cell immunofluorescence of 293T cells
expressing siRNA-resistant Cx43 (green) with
knockdown of endogenous Cx43. Nuclei were
detected with DAPI (blue); arrow: gap junction
plaque at the cell-cell border. Cell pairs were
randomly selected and assessed for the presence
of gap junction plaque for Cx43 constructs con-
taining additive methionine-to-leucine mutations
at M100, M125, M147, and M213. Cx43M4L en-
compasses all four mutations.
(B) Percentage of cell pairs with plaque.
(C) Fixed-cell immunofluorescence of 293T cells
coexpressing the control GW-CAT-V5 construct
or the GJA1-20k-V5 isoform (red) and siRNA-
resistant Cx43 (green). Nuclei were counterstained
with DAPI (blue); arrow: gap junction plaque at the
cell-cell border.
(D) Percentage of cell pairs from (C) assessed for
the presence of gap junction plaque. Original
magnification 3 100. Scale bar, 25 mm. Data are
presented asmean ±SEM. ***p < 0.001, **p < 0.01.
See also Figures S3 and S4.translation. Using primary neonatal mouse ventricular cardio-
myocytes (NMVMs), we found that inhibition of PI3K/AKT
signaling using the PI3K inhibitor GDC-0941 (Folkes et al.,
2008) increases expression of GJA1-20k (Figure S5). The
mTOR pathway is an established regulator of cap-dependent
protein translation, which is integral to PI3K/AKT signaling. Inhi-
bition of mTOR kinase activity using the inhibitor PP242 (Feld-
man et al., 2009) significantly augments expression of internally
translated isoforms in 293T cells transfected with Cx43DSTART,
revealing that this pathway acts independently of the cap and
first mRNA start codon, and directly inhibits internal or cap-inde-
pendent translation (Figure 4A). Just as we observed with P13K
inhibition, PP242 also increased expression of GJA1-20k in
NMVMs (Figure 4B). The early formation of additional Cx43 iso-
forms (Figure S2) and their regulation by the PI3K/AKT/mTOR
pathway (Figures 4A, 4B, and S4) indicate that truncated GJA1
isoforms originate from internal, cap-independent translation
events. Fixed-cell immunofluorescence of NMVMs incubated
for 16 hr with DMSO (left panels) or PP242 (right panels) is pre-
sented in Figure 4C. An increase in Cx43 (green) gap junction
density is apparent in cells treated with PP242, with N-cadherin
(red) identifying cell-cell borders. Quantification of the Cx43 fluo-
rescence intensity profiles of 10 mm vectors bisecting cell-cell
borders is presented in Figure 4D. Consistent with data pre-
sented in Figure 3, these findings implicate internally translated
Cx43 isoforms in positive regulation of gap junction formation.Cell Reports 5, 611–618, NCx43 has been implicated in cellular
processes that are apparently indepen-
dent of cell-cell communication, including
trafficking of other ion channels (Rhett
et al., 2012), mitochondrial regulation
(Rodriguez-Sinovas et al., 2006), and
cell-cycle regulation (Olbina and Eckhart,2003). It is possible that alternatively translated gene products
could be responsible for some of these observations. In recent
years, regulation of translation has emerged as a potentially
major component of cellular protein control, and the mTOR
pathway has been shown to play a central role in promoting
cap-dependent translation. The number of identified eukaryotic
IRES elements is increasing, with the majority occurring within
the 50 UTR of mRNAs to allow cap-independent translation
during mitosis and stress (Komar and Hatzoglou, 2011). Initiation
of translation within the mRNA coding sequence has also
been reported for proteins such as ECSIT, Myc, and NANOG,
yielding truncated gene products that can regulate full-length
protein function (Ingolia et al., 2011). Many ion channels require
subunits to chaperone their journey from the ER to the plasma
membrane (Smyth and Shaw, 2010). In this study, we present
the finding that GJA1 mRNA is in fact polycistronic, and several
N-terminally truncated Cx43 isoforms are generated at the trans-
lational level. These alternatively translated Cx43 ‘‘subunits’’ are
necessary for successful transport of the full-length protein to
the cell surface, and the subunit GJA1-20k in particular is suffi-
cient to affect this process. It is also possible that non-Cx43
ion channels and other proteins without known chaperones
may undergo similar autoregulation. Cap-independent transla-
tion events therefore represent a potential target for protein regu-
lation and therapeutic restoration of normal electrical coupling in
diseased hearts.ovember 14, 2013 ª2013 The Authors 615
Figure 4. Expression of Cx43 Truncated Isoforms Is Regulated by the mTOR Pathway
(A) 293T cells transfected with siRNA-resistant Cx43 or Cx43DSTART with knockdown of endogenous Cx43 incubated for 8 hr in the presence or absence of the
mTOR kinase inhibitor PP242. Cx43 was detected by western blot.
(B) Primary NMVMs were incubated for 16 hr with DMSO or PP242. Cx43 was detected by western blot, with quantitation of the C-terminal fragment relative to
full-length Cx43 (43 kDa) in the graph.
(C) Fixed-cell immunofluorescence of cells from (B). Cell borders are identified with N-cadherin (red) for quantification of Cx43 (green) gap junction density.
Original magnification 3 60. Scale bar, 25 mm.
(D) Averaged fluorescence intensity profiles of Cx43 expression at cell-cell borders. Data are presented as mean ± SEM. **p < 0.01, *p < 0.05.
See also Figure S5.EXPERIMENTAL PROCEDURES
Human Tissue Acquisition
With the approval of the UCSF Committee for Human Research, we obtained
tissue from the hearts of organ donors whose hearts had not been trans-
planted for technical reasons. The California Transplant Donor Network pro-
vided the unused donor hearts and obtained informed consent for their use
from the next of kin.616 Cell Reports 5, 611–618, November 14, 2013 ª2013 The AuthorsMice
All procedures were reviewed and approved by the University of California
Institutional Animal Care and Use Committee.
Molecular Biology
Human GJA1 was obtained from Open Biosystems and cloned into pDONR/
221 and pcDNA3.2/V5-Dest using Gateway technology (Life Technologies).
Constructs encoding N- and C-terminal HA-epitope-tagged Cx43, and
C-terminal EGFP and mCherry fusion proteins were generated as previously
described (Smyth et al., 2012). Mutagenesis was performed using the
QuikChange Lightning Mutagenesis Kit (Agilent) according to the manufac-
turer’s instructions.
In vitro transcription was undertaken using the T7 mScript Standard mRNA
Production System (Cellscript) and pcDNA3.2-huCx43 or pcDNA3.2-EGFP as
the template. Stealth siRNA duplexes targeting human GJA1 were obtained
from Life Technologies. Plasmids are available at the nonprofit repository
Addgene (http://www.addgene.org/Robin_Shaw/).
NMVM Isolation and Culture
P1 NMVMs were isolated and maintained in culture as previously
described (Smyth et al., 2012). For inhibitor experiments, cells were insulin
starved and fetal bovine serum dropped to 1% in Dulbecco’s modified
Eagle’s medium/F12 for 8 hr prior to addition of GDC-0941 (2.5 mM),
PP242 (5 mM), or DMSO. Following 30 min of incubation, insulin
was added to a final concentration of 10 mg/ml and cells were fixed for
immunofluorescence or harvested for biochemistry 1 hr and 16 hr after
stimulation.
Western Blotting
Lysates were prepared in RIPA buffer and western blotting was performed
as previously described (Smyth et al., 2010; Smyth et al., 2012). Mouse mono-
clonal anti-Cx43 directed against C-terminal (1/3000) and N-terminal (1/2,000)
regions was obtained from the Fred Hutchinson Cancer Research Center.
Mouse monoclonal anti-a-tubulin (1/3,000), anti-HA (1/5,000), and rabbit
polyclonal anti-Cx43 (1/3,000) were obtained from Sigma-Aldrich. Rabbit
polyclonal antibodies against AKT (1/1,000) and phosoho-AKTSer473
(1/1,000) were obtained from Cell Signaling Technology.
Immunofluorescence
Cells were cotransfected with pcDNA3.2-GW-CAT-V5 as a transfection
control, or pcDNA3.2-GJA1213-382-V5, together with either wild-type or
mutated pcDNA3.2-huCx43-Stop. Eighteen hours after transfection, the
cells were fixed with 4% paraformaldehyde and immunostained for Cx43
(rabbit polyclonal 1/3,000; Sigma) and V5 tag (mouse monoclonal 1/1,000;
Sigma) with AlexaFluor488 and AlexaFluor555 (Life Technologies) as
previously described (Smyth et al., 2010). For mouse monoclonal Golgi
apparatus marker 58K (1/200; Abcam) and ER marker PDI (1/200; Abcam)
immunodetection, cells were fixed in ice-cold methanol for 5 min. Monoclonal
N-cadherin (1/250; BD Biosciences) was used to detect cell-cell borders in
NMVMs.
Slideswere imaged using aNikon Timicroscope with a3 100/1.49 Apo TIRF
objective, YokogowaCSU-X1 spinning-disk confocal unit with 486 and 561 nm
laser sources, and Coolsnap HQ2 camera controlled by NIS Elements
software.
Quantification of Cx43 Gap Junction Plaque Formation
Cell pairs were screened in blinded fashion for comparable levels of V5-tag
and then assessed for the presence of Cx43 gap junction plaque. A total of
75 cell pairs were assessed for each condition.
Quantification of Cx43 Gap Junction Plaque Density
For quantification of Cx43 expression at cell-cell borders (Figure 4C),
we generated maximum intensity projections of 10 mm confocal z stacks
for N-cadherin (to identify cell-cell borders) and Cx43. We then implemented
a MATLAB routine that generates 10 mm fluorescence intensity profiles
bisecting traced cell-cell borders, automating a previously described quantifi-
cation technique (Smyth et al., 2012). This routine is freely available upon
request.
Statistical Analysis
All data are presented as mean ± SEM, and Student’s t test or one-way
ANOVA (with Bonferroni post test) was used accordingly. A p value < 0.05
was considered significant.CeSUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2013.10.009.
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